与乙氨基相关的急性肝衰竭中的非结合性高 bilirubinemia
Marie Philippart1, Jean-Baptiste Mesland1, Vincent Haufroid2
1Department of Intensive Care, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
The American journal of case reports
|March 22, 2024
概括
在乙氨基引起的肝衰竭中,高的非结合性 bilirubin 是不寻常的. 这种情况表明胆红素结合的持续缺陷,可能与肝损伤有关,但其预后值仍然不确定.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 毒理学 毒理学 毒理学
- 生物化学 生物化学
背景情况:
- 过量服用乙氨基可能导致急性肝衰竭.
- 肝衰竭通常表现为结合性 bilirubin 的增加.
- 高水平的非结合性 bilirubin 是罕见的,在这个背景下不太了解.
研究的目的:
- 在乙氨基诱导的肝衰竭中调查高非结合性白素的原因.
- 探索非结合性高 bilirubinemia的潜在的预后影响.
主要方法:
- 一个52岁的男性患有乙氨基引起的肝衰竭的病例报告.
- 临床监测,包括神经状态和凝血.
- 实验室分析胆红素水平 (结合和未结合) 并排除血液溶解.
- 对吉尔伯特综合征的评估.
主要成果:
- 患者出现了IV级脑病变和严重的凝血病变.
- 血清未结合胆红素的逐步上升,尽管N-乙半氨酸治疗.
- 血液溶解和吉尔伯特综合征被排除在外.
- 由于精神病学评估,肝移植被认为不适合.
结论:
- 持续的非结合性高 bilirubinemia 可能表明与心球肝损伤相关的 bilirubin 结合的缺陷.
- 与乙氨基葡萄糖化直接联系是未知的.
- 目前没有足够的数据来确定未结合/结合比利鲁宾的比率作为预后因素.
相关概念视频
Phase II Reactions: Acetylation Reactions
223
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
223
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
199
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
199
Hepatic Drug Excretion: Influencing Factors
128
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
128
Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K
Acute Pancreatitis II: Clinical Manifestations and Management
122
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
122
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
196
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
196


